References
- Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells, EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009; 361:1935–1944.
- O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010; 182(1):39–44
- Cullen G, Martin J, O'Donnell J, Boland M, Canny M, Keane E, McNamara A, O'Hora A, Fitzgerald M, Jackson S, Igoe D, O'Flanagan D. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April–3 October 2009. Euro Surveill. 2009 Nov 5;14(44). pii: 19389 (Erratum in: Euro Surveill. 2009;14(45) pii: 19398).
- Jartti T, Ruuskanen O. Influenza virus and acute asthma in children. Pediatrics 2008; 121:1079–1080; author reply 1080.
- Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, Teague WG. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007; 119:314–321.
- Bueving HJ, Bernsen RM, de Jongste JC, van Suijlekom-Smit LW, Rimmelzwaan GF, Osterhaus AD, Rutten-van Molken MP, Thomas S, van der Wouden JC. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004; 169:488–493.
- Johnston SL, Ferrero F, Garcia ML, Dutkowski R. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. Pediatr Infect Dis J 2005; 24:225–232.
- Global Initiative for Asthma (GINA). GINA report, global strategy for asthma management and prevention. 2008. Available at: www.ginasthma.com/. Accessed January 15, 2009.
- Centers for Disease Control and Prevention (CDC). Available at: www.cdc.gov/flu/. Accessed December 13, 2009.
- Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59–99.
- Groupes Régionaux d'Observation de la Grippe (GROG). Available at: www.grog.org/. Accessed December 15, 2009.
- Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, Roy M, Waserman S, Sears MR. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005; 115:132–138.
- Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 2008; 122:662–668; quiz 669–670.
- World Health Organization (WHO). Available at: www.who.int/csr/disease/influenza/en/. Accessed December 15, 2009.
- Institut de Veille Sanitaire (INVS). Available at: www.invs.sante.fr/. Accessed December 12, 2009.
- Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, Jala M, Bidaud-Chevalier B, Dinh-Xuan AT, Randrianarivelo O, Denjean A, de Blic J, Delclaux C. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity. Allergy 2010; 65:636–644.
- Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836–844.